T1	Participants 32 50	hepatic amoebiasis
T2	Participants 119 154	31 patients with hepatic amoebiasis
T3	Participants 156 266	Only those with unequivocal clinical, radiological and laboratory evidence of hepatic amoebiasis were included
T4	Participants 337 406	15 patients received metronidazole and 16 tinidazole, in random order
T5	Participants 880 912	hepatic amoebiasis in Bangladesh
